{"title":"Haemophagocytic Lymphohistiocytosis as an Initial Presentation of Undiagnosed Systemic Lupus Erythematosus.","authors":"Lujain K Alharbi, Alaa K Ahmed","doi":"10.12890/2025_005336","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Haemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal hyperinflammatory syndrome with multi-organ involvement. It may occur secondary to autoimmune diseases such as systemic lupus erythematosus (SLE).</p><p><strong>Case description: </strong>This report describes an unusual case of a previously healthy 29-year-old female medical student who presented with a one-month history of recurrent fever, fatigue and significant weight loss. Initial laboratory investigations revealed pancytopaenia, hyperferritinaemia and hypertriglyceridaemia. Infectious disease workup was negative. Serological testing demonstrated positive antinuclear antibody and anti-double-stranded DNA antibodies, while bone marrow biopsy confirmed haemophagocytosis. The patient was diagnosed with secondary HLH due to SLE. During treatment in the intensive care unit, the patient developed psychosis manifested by visual hallucinations and mood swings. A diagnosis of neuropsychiatric SLE was confirmed by exclusion of other causes (e.g. steroid therapy) and the presence of non-specific white matter hyperintensities on brain magnetic resonance imaging. Combination therapy with high-dose corticosteroids, intravenous immunoglobulin and rituximab resulted in significant clinical and laboratory improvements within two weeks.</p><p><strong>Conclusion: </strong>This case illustrates how HLH can be the initial manifestation of previously undiagnosed SLE. Hence, clinicians should maintain a high index of suspicion for underlying autoimmune disorders such as SLE when evaluating patients with HLH, as early recognition and appropriate immunosuppressive therapy are crucial for optimal outcomes.</p><p><strong>Learning points: </strong>Clinicians should suspect haemophagocytic lymphohistiocytosis in patients with persistent fever and cytopaenias, especially when laboratory findings (e.g. hyperferritinaemia, hypertriglyceridaemia) do not improve with standard treatments.Systemic lupus erythematosus may initially present as secondary haemophagocytic lymphohistiocytosis. Integration of clinical, radiological and immunological data can aid in early differentiation.</p>","PeriodicalId":11908,"journal":{"name":"European journal of case reports in internal medicine","volume":"12 5","pages":"005336"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12061209/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of case reports in internal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12890/2025_005336","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Haemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal hyperinflammatory syndrome with multi-organ involvement. It may occur secondary to autoimmune diseases such as systemic lupus erythematosus (SLE).
Case description: This report describes an unusual case of a previously healthy 29-year-old female medical student who presented with a one-month history of recurrent fever, fatigue and significant weight loss. Initial laboratory investigations revealed pancytopaenia, hyperferritinaemia and hypertriglyceridaemia. Infectious disease workup was negative. Serological testing demonstrated positive antinuclear antibody and anti-double-stranded DNA antibodies, while bone marrow biopsy confirmed haemophagocytosis. The patient was diagnosed with secondary HLH due to SLE. During treatment in the intensive care unit, the patient developed psychosis manifested by visual hallucinations and mood swings. A diagnosis of neuropsychiatric SLE was confirmed by exclusion of other causes (e.g. steroid therapy) and the presence of non-specific white matter hyperintensities on brain magnetic resonance imaging. Combination therapy with high-dose corticosteroids, intravenous immunoglobulin and rituximab resulted in significant clinical and laboratory improvements within two weeks.
Conclusion: This case illustrates how HLH can be the initial manifestation of previously undiagnosed SLE. Hence, clinicians should maintain a high index of suspicion for underlying autoimmune disorders such as SLE when evaluating patients with HLH, as early recognition and appropriate immunosuppressive therapy are crucial for optimal outcomes.
Learning points: Clinicians should suspect haemophagocytic lymphohistiocytosis in patients with persistent fever and cytopaenias, especially when laboratory findings (e.g. hyperferritinaemia, hypertriglyceridaemia) do not improve with standard treatments.Systemic lupus erythematosus may initially present as secondary haemophagocytic lymphohistiocytosis. Integration of clinical, radiological and immunological data can aid in early differentiation.
期刊介绍:
The European Journal of Case Reports in Internal Medicine is an official journal of the European Federation of Internal Medicine (EFIM), representing 35 national societies from 33 European countries. The Journal''s mission is to promote the best medical practice and innovation in the field of acute and general medicine. It also provides a forum for internal medicine doctors where they can share new approaches with the aim of improving diagnostic and clinical skills in this field. EJCRIM welcomes high-quality case reports describing unusual or complex cases that an internist may encounter in everyday practice. The cases should either demonstrate the appropriateness of a diagnostic/therapeutic approach, describe a new procedure or maneuver, or show unusual manifestations of a disease or unexpected reactions. The Journal only accepts and publishes those case reports whose learning points provide new insight and/or contribute to advancing medical knowledge both in terms of diagnostics and therapeutic approaches. Case reports of medical errors, therefore, are also welcome as long as they provide innovative measures on how to prevent them in the current practice (Instructive Errors). The Journal may also consider brief and reasoned reports on issues relevant to the practice of Internal Medicine, as well as Abstracts submitted to the scientific meetings of acknowledged medical societies.